BindingDB logo
myBDB logout
Compile Data Set for Download or QSAR

Found 1 hit Enz. Inhib. hit(s) with Target = 'Transient receptor potential cation channel subfamily V member 1' and Ligand = 'BDBM125074'   
Target/Host
(Institution)
LigandTarget/Host
Links
Ligand
Links
Trg + Lig
Links
Ki
nM
ΔG°
kJ/mole
IC50
nM
Kd
nM
EC50/IC50
nM
koff
s-1
kon
M-1s-1
pHTemp
°C
Transient receptor potential cation channel subfamily V member 1


(Homo sapiens (Human))
BDBM125074
PNG
(US8765733, 63)
Show SMILES CC(C(=O)NCc1ccc(nc1N1CCC(C)CC1)C(F)(F)F)c1ccc(CN(C)S(C)(=O)=O)c(F)c1
Show InChI InChI=1S/C25H32F4N4O3S/c1-16-9-11-33(12-10-16)23-19(7-8-22(31-23)25(27,28)29)14-30-24(34)17(2)18-5-6-20(21(26)13-18)15-32(3)37(4,35)36/h5-8,13,16-17H,9-12,14-15H2,1-4H3,(H,30,34)
PDB
MMDB

Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem

Similars

US Patent
55n/an/an/an/an/an/an/an/a



Gruenenthal GmbH

US Patent


Assay Description
The FLIPR protocol consists of 2 substance additions. First the compounds to be tested (10 μM) are pipetted onto the cells and the Ca2+ influx i...


US Patent US8765733 (2014)


BindingDB Entry DOI: 10.7270/Q2BZ64QQ
More data for this
Ligand-Target Pair